• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Recursion Pharmaceuticals, Inc. - Class A Common Stock (NQ:RXRX)

    5.910 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 28, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Recursion Pharmaceuticals, Inc. - Class A Common Stock

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    16 17 Next >
    AI Revolutionizes Drug Discovery and Personalized Medicine: A New Era of Healthcare
    The pharmaceutical and biotechnology industries are undergoing a profound transformation, driven by an urgent need for more efficient drug discovery and development processes and the paradigm shift... 
    Via TokenRing AI
    Topics Animal Testing Artificial Intelligence
    Looking For The Next Beyond Meat? Here Are The Top 10 Most Shorted Stocks
    Here's a look at the most heavily shorted stocks in the market as investors look for the next Beyond Meat. 
    Via Benzinga
    Short Squeeze Frenzy Fuels October's Market Rebound: A Closer Look at Bearish Bets and Bullish Surges
    The U.S. stock market has staged a remarkable recovery in October 2025, with major indices reclaiming lost ground amidst a confluence of positive corporate earnings and improving macroeconomic... 
    Via MarketMinute
    Topics Economy Stocks World Trade
    Recursion Pharmaceuticals (RXRX) CEO Sells 100,000 Shares
    Via The Motley Fool
    Up 25% in 1 Month, Is This Stock a Buy?
    It might look like this beaten-down AI-focused company is finally bouncing back, but don't be too quick to pull the trigger. 
    Via The Motley Fool
    Topics Animal Testing Artificial Intelligence
    WW International, Replimune Group, Datavault AI, GRAIL And Other Big Stocks Moving Higher On Monday
     
    Via Benzinga
    Topics Artificial Intelligence
    3 Growth Stocks to Invest $1,000 in Right Now
    Not every promising prospect is currently priced too richly relative to its risk. 
    Via The Motley Fool
    Most active stocks in Thursday's session
    Stay updated with the latest market activity on Thursday. Explore the most active stocks in today's session and stay informed about the stocks that are in the spotlight. 
    Via Chartmill
    Is Recursion Pharmaceuticals a Millionaire Maker?
    This is the only biotech stock to attract an investment from artificial intelligence (AI) giant Nvidia. 
    Via The Motley Fool
    Topics Artificial Intelligence Initial Public Offering
    Morgan Stanley, T1 Energy, Bunge Global, Bank of America And Other Big Stocks Moving Higher On Wednesday
     
    Via Benzinga
    AI Agents Usher in a New Era of Pharmaceutical Discovery: Accelerating Cures to Market
    The pharmaceutical industry stands on the precipice of a revolutionary transformation, driven by the burgeoning power of artificial intelligence (AI) agents. These sophisticated, autonomous systems are... 
    Via TokenRing AI
    Topics Artificial Intelligence Intellectual Property
    Absci's AI Revolution: A New Era for Drug Discovery or a Rocky Road Ahead?
    Absci (NASDAQ: ABSI), a pioneer in AI-driven drug discovery, is making significant strides with its "Integrated Drug Creation™ Platform," promising to revolutionize how new medicines are brought to... 
    Via MarketMinute
    Topics Artificial Intelligence
    2 Reasons Absci Could Be the Future of AI Biotech, and 1 Risk
    Absci's AI drug development platform is compelling, and its pipeline is promising...but can the company overcome execution hurdles to live up to analyst hype? 
    Via MarketBeat
    Topics Artificial Intelligence
    4 Healthcare Stocks to Buy Now
    As investors crowd into AI names at record highs, these three healthcare stocks offer more compelling valuations. 
    Via The Motley Fool
    Topics Artificial Intelligence
    Costco, AMD, Recursion Pharmaceuticals, Cipher Mining And Snowflake: Why These 5 Stocks Are On Investors' Radars Today
    On Wednesday, major U.S. indices closed mixed, with the Nasdaq rising 1.1% to 23,043.38 and the S&P 500 slipping nearly 0.6% to 6,753.72. The Dow Jones Industrial Average was unchanged at... 
    Via Benzinga
    Topics Stocks
    What's Going On With Recursion Pharmaceuticals Stock On Wednesday?
    Recursion Pharmaceuticals' stock rises on heavy trading volume, with investors eyeing its AI-designed cancer drug REC-3565 and extended cash runway. 
    Via Benzinga
    10 Health Care Stocks Whale Activity In Today's Session
     
    Via Benzinga
    Dell, Select Medical, Century Aluminum And Other Big Stocks Moving Higher On Wednesday
     
    Via Benzinga
    Decoding Life's Blueprint: New Tech Maps RNA-Protein Interactions, Unlocking Disease Cures
    A monumental leap in biomedical research has been announced with the development of a breakthrough technology capable of mapping the entire intricate network of RNA-protein interactions within human... 
    Via MarketMinute
    Topics Artificial Intelligence Derivatives
    AI Revolutionizes Professional Services: A New Era for Doctors, Lawyers, and Consultants
    As of October 1, 2025, Artificial Intelligence (AI) has transcended its nascent stages, becoming an indispensable force in high-value professional tasks across medicine, law, and consulting. This... 
    Via MarketMinute
    Topics Artificial Intelligence
    Nvidia Has Invested in These 6 Companies. Should You Follow Suit?
    The world's most valuable company holds stakes in a number of smaller tech players. 
    Via The Motley Fool
    Topics Artificial Intelligence
    Where Will Recursion Pharmaceuticals Be in 5 Years?
    Could investing in this stock be an underrated way to profit from the rapidly expanding AI industry? 
    Via The Motley Fool
    Topics Animal Testing Artificial Intelligence
    The Biotech Stock That's Too Risky for Most Investors
    It's unclear how long it's going to be before this company has a product to sell. 
    Via The Motley Fool
    Topics Artificial Intelligence
    10 Hidden-Gem AI Stocks to Buy Right Now
    From AI-powered insurance bots to drug discovery platforms, these overlooked stocks offer pure-play exposure to artificial intelligence without trillion-dollar valuations. 
    Via The Motley Fool
    Topics Artificial Intelligence
    Cramer's Friday Watchlist: AI Soars as Consumer Stumbles Amidst Economic Divide
    As the trading week draws to a close on Friday, September 26, 2025, Jim Cramer, the influential host of CNBC's "Mad Money," has once again offered his discerning insights into the stock market's... 
    Via MarketMinute
    Topics Artificial Intelligence Economy Energy
    Jim Cramer Says This Financial Stock Is A 'Total Spec,' Likes Dutch Bros,
    On CNBC's “Mad Money Lightning Round,” Jim Cramer said he likes Dutch Bros (NYSE: BROS). He recommended buying some now and then buying some of the stock in the $40s. 
    Via Benzinga
    Prediction: 2 Stocks That Will Be Worth More Than BigBear.ai 5 Years From Now
    BigBear.ai is bigger than both of these AI-focused companies now. That could change. 
    Via The Motley Fool
    Topics Artificial Intelligence
    The Pharmaceutical Revolution: AI, Gene Therapies, and Obesity Drugs Reshape a Trillion-Dollar Market
    The global pharmaceutical sector stands at the precipice of a monumental transformation, driven by an unprecedented convergence of scientific breakthroughs, technological innovation, and evolving... 
    Via MarketMinute
    Topics Artificial Intelligence Economy Intellectual Property
    Lilly's AI Gambit: TuneLab Poised to Reshape Biotech Drug Discovery Landscape
    Eli Lilly and Company (NYSE: LLY) has unveiled its groundbreaking TuneLab Platform, an artificial intelligence (AI) and machine learning (ML) initiative designed to democratize advanced drug discovery... 
    Via MarketMinute
    Topics Animal Testing Artificial Intelligence Intellectual Property
    Nvidia Has $4.3 Billion Invested in These 6 Artificial Intelligence (AI) Stocks. Here's the Best of the Bunch.
    Most of Nvidia's AI bets are riding on one stock. 
    Via The Motley Fool
    Topics Artificial Intelligence
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    16 17 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.